Enanta Pharmaceuticals | ENTA - Market Capitalization


Enanta Pharmaceuticals reported $315.9M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 301.25B 13.1B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Incyte USD 21.73B 3B May/2026
Insmed USD 37.12B 6.68B Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Merck USD 297.1B 35.84B Mar/2026
Neurocrine Biosciences USD 13.34B 800M May/2026
Novartis USD 232.75B 75B May/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 148.08B 6.51B May/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Vertex Pharmaceuticals USD 111.03B 2.55B May/2026